Work

Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma

Year: 2015

Type: article

Source: Leukemia

DOI: 10.1038/leu.2015.54

Authors: N Shah, P F Thall, P S Fox, Q Bashir, J J Shah, S Parmar, P Lin, P Kebriaei, Y Nieto, U R Popat, C M Hosing, A Cornelison, E J Shpall, R Z Orlowski, R E Champlin, M H Qazilbash

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G3758881957, Cancer Center Support Grant

OpenAlex ID: W2113998530

FWCI: 2.604

Cites: 17

Cited by: 12

Related to: 10